{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:43:10Z","timestamp":1783550590879,"version":"3.55.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["50-53000-98-103"],"award-info":[{"award-number":["50-53000-98-103"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Introduction<\/jats:title>\n<jats:p>Population-based <jats:italic>Chlamydia trachomatis<\/jats:italic> (CT) serology studies help evaluate the effectiveness of CT-control strategies. Determinants of CT seropersistence over time are largely unknown, but may include host genetic factors. This study aims to assess seropositivity, map antibody trajectories, and identify determinants of seropositivity and seropersistence.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We analyzed anti-chlamydial immunoglobulin G levels in serum of women of reproductive age who participated in a prospective cohort and CT screening study. CT history was determined using screening results and self-reported diagnoses from sexual debut onward. We assessed seropersistence for n\u2009=\u20091,405 participants with samples at baseline and after six years, and seropositivity for n\u2009=\u20092,997 participants with baseline samples. Multivariable logistic regression identified demographic, behavioral, and host single nucleotide polymorphism (SNP) factors associated with seropersistence and seropositivity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among seropositive women at baseline, 42.0% (n\u2009=\u2009118\/281) were seropositive at follow-up. Seropersistence was more often found in women who reported treated asymptomatic and symptomatic CT infections as compared to those who did not (aOR: 3.74, 95%CI: 1.75\u20138.15 and 4.79, 95%CI: 2.42\u20139.47, respectively). Other associated factors were higher baseline antibody titers, carrying SNPs in TLR2 (aOR: 3.06, 95%CI: 1.31\u20137.36) and TLR9 (2.09, 95%CI: 1.09\u20134.08) genes and practical education (aOR: 3.16, 95%CI: 1.56\u20136.64). Seropositivity (24.9%, n\u2009=\u2009748\/2,997) was associated with a CCR5 deletion (aOR: 0.65, 95%CI: 0.42\u20130.99).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>CT seropersistence was more often found in women who reported treated CT infections as compared to women who did not report having had a CT infection or receiving treatment for it. Genetic predisposition and behavioral factors are linked to diversity in seropersistence patterns.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0328449","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:23:41Z","timestamp":1754414621000},"page":"e0328449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prevalence and risk factors for Chlamydia trachomatis seropositivity and seropersistence among women: A prospective cohort study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-8904","authenticated-orcid":true,"given":"Zo\u00efe W.","family":"Alexiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice M.","family":"Hoenderboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1815-0974","authenticated-orcid":true,"given":"Christian J. P. A.","family":"Hoebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Scholte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshtrie","family":"Sheombarsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole H.T.M.","family":"Dukers-Muijrers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit H.B.","family":"van Benthem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Servaas A.","family":"Morr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"pone.0328449.ref001","unstructured":"WHO. Fact sheet: Sexually transmitted infections (STIs). 2022. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis)"},{"issue":"22","key":"pone.0328449.ref002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20220","article-title":"The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis","volume":"20","author":"MJ Price","year":"2016","journal-title":"Health Technol Assess"},{"issue":"1","key":"pone.0328449.ref003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/sextrans-2017-053478","article-title":"National prevalence estimates of chlamydia and gonorrhoea in the Netherlands","volume":"95","author":"JCM Heijne","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"2","key":"pone.0328449.ref004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/OLQ.0b013e318151497d","article-title":"The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment","volume":"35","author":"WM Geisler","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"12","key":"pone.0328449.ref005","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00356-0","article-title":"Frequent screening for asymptomatic chlamydia and gonorrhoea infections in men who have sex with men: time to re-evaluate?","volume":"23","author":"E Williams","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"pone.0328449.ref006","doi-asserted-by":"crossref","first-page":"100743","DOI":"10.1016\/j.lanepe.2023.100743","article-title":"Management of asymptomatic sexually transmitted infections in Europe: towards a differentiated, evidence-based approach","volume":"34","author":"C Kenyon","year":"2023","journal-title":"The Lancet Regional Health - Europe"},{"issue":"10","key":"pone.0328449.ref007","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/microorganisms7100442","article-title":"Antibody Testing in Estimating Past Exposure to Chlamydia trachomatis in The Netherlands Chlamydia Cohort Study","volume":"7","author":"BM Hoenderboom","year":"2019","journal-title":"Microorganisms"},{"issue":"12","key":"pone.0328449.ref008","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(18)30159-2","article-title":"Advancing the public health applications of Chlamydia trachomatis serology","volume":"18","author":"SC Woodhall","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pone.0328449.ref009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152810","article-title":"Chlamydia trachomatis Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012)","volume":"12","author":"SC Woodhall","year":"2017","journal-title":"PLOS ONE"},{"issue":"8","key":"pone.0328449.ref010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072001","article-title":"C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010","volume":"8","author":"P Horner","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"pone.0328449.ref011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/sextrans-2018-053915","article-title":"Prevalence and persistence of Chlamydia trachomatis-specific antibodies after occasional and recurrent infections","volume":"96","author":"H \u00d6hman","year":"2020","journal-title":"Sexually Transmitted Infections"},{"issue":"11","key":"pone.0328449.ref012","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/infdis\/jix194","article-title":"Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection","volume":"215","author":"RK Bakshi","year":"2017","journal-title":"J Infect Dis"},{"issue":"12","key":"pone.0328449.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208652","article-title":"Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infections","volume":"13","author":"PB Blomquist","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"pone.0328449.ref014","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/OLQ.0000000000000605","article-title":"Chlamydia trachomatis incidence using self-reports and serology by gender, age period, and sexual behavior in a birth cohort","volume":"44","author":"AA Righarts","year":"2017","journal-title":"Sexually Transmitted Diseases"},{"key":"pone.0328449.ref015","doi-asserted-by":"crossref","first-page":"729016","DOI":"10.3389\/fmicb.2021.729016","article-title":"Seroepidemiology of Chlamydia trachomatis Infection in the General Population of Northern China: The Jidong Community Cohort Study","volume":"12","author":"J Shui","year":"2021","journal-title":"Frontiers in Microbiology"},{"issue":"1","key":"pone.0328449.ref016","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1186\/s12879-018-3533-7","article-title":"Differences in Chlamydia trachomatis seroprevalence between ethnic groups cannot be fully explained by socioeconomic status, sexual healthcare seeking behavior or sexual risk behavior: a cross-sectional analysis in the HEalthy LIfe in an Urban Setting (HELIUS) study","volume":"18","author":"SH Hulstein","year":"2018","journal-title":"BMC Infectious Diseases"},{"issue":"3","key":"pone.0328449.ref017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151497","article-title":"Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study","volume":"11","author":"PJ Horner","year":"2016","journal-title":"PLoS ONE"},{"key":"pone.0328449.ref018","article-title":"Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years","author":"ZW Alexiou","year":"2023","journal-title":"Sex Transm Infect"},{"issue":"3","key":"pone.0328449.ref019","article-title":"Neutralizing Antibody Responses to Chlamydia trachomatis in Women and Associations With Chlamydia Outcomes","volume":"231","author":"H Yu","year":"2025","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0328449.ref020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0966-842X(02)00011-2","article-title":"The cellular paradigm of chlamydial pathogenesis","volume":"11","author":"RS Stephens","year":"2003","journal-title":"Trends Microbiol"},{"key":"pone.0328449.ref021","first-page":"45","article-title":"Host genetic contribution to the cellular immune response to Chlamydia trachomatis: heritability estimate from a Gambian twin study","volume":"45","author":"RL Bailey","year":"2009","journal-title":"Drugs Today (Barc)"},{"issue":"2","key":"pone.0328449.ref022","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1574-695X.2009.00536.x","article-title":"Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics","volume":"55","author":"SA Morre","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"pone.0328449.ref023","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12879-017-2376-y","article-title":"The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women","volume":"17","author":"BM Hoenderboom","year":"2017","journal-title":"BMC Infectious Diseases"},{"key":"pone.0328449.ref024","doi-asserted-by":"crossref","first-page":"101027","DOI":"10.1016\/j.lanepe.2024.101027","article-title":"Reproductive tract complication risks following Chlamydia trachomatis infections: a long-term prospective cohort study from 2008 to 2022","volume":"45","author":"ZW Alexiou","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"pone.0328449.ref025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2334-10-89","article-title":"Evaluation design of a systematic, selective, internet-based, Chlamydia screening implementation in the Netherlands, 2008-2010: implications of first results for the analysis","volume":"10","author":"IV van den Broek","year":"2010","journal-title":"BMC Infect Dis"},{"key":"pone.0328449.ref026","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.mimet.2017.11.022","article-title":"Chlamydia trachomatis antibody detection in home-collected blood samples for use in epidemiological studies","volume":"144","author":"BM Hoenderboom","year":"2018","journal-title":"Journal of Microbiological Methods"},{"key":"pone.0328449.ref027","volume-title":"Performance Evaluation Report SERION ELISA Classic Chlamydia trachomatis IgG","author":"IVS GmbH","year":"2018"},{"key":"pone.0328449.ref028","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4939-0446-4_7","article-title":"SNP genotyping: the KASP assay","volume":"1145","author":"C He","year":"2014","journal-title":"Methods Mol Biol"},{"key":"pone.0328449.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiab016","article-title":"Multipeptide assays for sensitive and differential detection of anti-chlamydia trachomatis antibodies","volume":"224","author":"KS Rahman","year":"2021","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0328449.ref030","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/sextrans-2011-050386","article-title":"Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study","volume":"89","author":"PJ Horner","year":"2013","journal-title":"Sexually Transmitted Infections"},{"issue":"8","key":"pone.0328449.ref031","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/IAI.01377-07","article-title":"The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells","volume":"76","author":"Z Li","year":"2008","journal-title":"Infect Immun"},{"issue":"8","key":"pone.0328449.ref032","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/sextrans-2023-055808","article-title":"Using infection prevalence, seroprevalence and case report data to estimate chlamydial infection incidence","volume":"99","author":"PA Clay","year":"2023","journal-title":"Sex Transm Infect"},{"issue":"8","key":"pone.0328449.ref033","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/cid\/ciab506","article-title":"High Plasmid Gene Protein 3 (Pgp3) Chlamydia trachomatis Seropositivity, Pelvic Inflammatory Disease, and Infertility Among Women, National Health and Nutrition Examination Survey, United States, 2013-2016","volume":"73","author":"GE Anyalechi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0328449.ref034","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.fertnstert.2015.08.022","article-title":"Chlamydia trachomatis immunoglobulin G3 seropositivity is a predictor of reproductive outcomes in infertile women with patent fallopian tubes","volume":"104","author":"AZ Steiner","year":"2015","journal-title":"Fertil Steril"},{"issue":"5","key":"pone.0328449.ref035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/jcm.23.5.924-928.1986","article-title":"Persistence of chlamydial antibodies after pelvic inflammatory disease","volume":"23","author":"M Puolakkainen","year":"1986","journal-title":"Journal of Clinical Microbiology"},{"issue":"12","key":"pone.0328449.ref036","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/infdis\/jit094","article-title":"Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection","volume":"207","author":"WM Geisler","year":"2013","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0328449.ref037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/OLQ.0b013e31815e41a3","article-title":"The arrested immunity hypothesis and the epidemiology of chlamydia control","volume":"35","author":"RC Brunham","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"11","key":"pone.0328449.ref038","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14760584.2022.2117694","article-title":"Chlamydia trachomatisvaccine development \u2013 a view on the current challenges and how to move forward","volume":"21","author":"\u00c1H Borges","year":"2022","journal-title":"Expert Review of Vaccines"},{"issue":"6","key":"pone.0328449.ref039","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13216","article-title":"The impact of obesity on immune response to infection: plausible mechanisms and outcomes","volume":"22","author":"G Muscogiuri","year":"2021","journal-title":"Obes Rev"},{"issue":"4","key":"pone.0328449.ref040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/sextrans-2018-053915","article-title":"Prevalence and persistence of Chlamydia trachomatis-specific antibodies after occasional and recurrent infections","volume":"96","author":"H Ohman","year":"2020","journal-title":"Sex Transm Infect"},{"issue":"12","key":"pone.0328449.ref041","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/infdis\/jis621","article-title":"Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection","volume":"206","author":"WM Geisler","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0328449.ref042","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/pathogens10010048","article-title":"Can previous associations of single nucleotide polymorphisms in the TLR2, NOD1, CXCR5, and IL10 genes in the susceptibility to and severity of Chlamydia trachomatis infections be confirmed?","volume":"10","author":"JB Jukema","year":"2021","journal-title":"Pathogens"},{"issue":"1","key":"pone.0328449.ref043","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftv107","article-title":"TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women","volume":"74","author":"SP Verweij","year":"2015","journal-title":"Pathogens and Disease"},{"issue":"6","key":"pone.0328449.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039460","article-title":"TLR2, but Not TLR4, Is Required for Effective Host Defence against Chlamydia Respiratory Tract Infection in Early Life","volume":"7","author":"EL Beckett","year":"2012","journal-title":"PLoS ONE"},{"issue":"11","key":"pone.0328449.ref045","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.4049\/jimmunol.171.11.6187","article-title":"Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection","volume":"171","author":"T Darville","year":"2003","journal-title":"J Immunol"},{"issue":"8","key":"pone.0328449.ref046","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1007\/s11033-012-1695-8","article-title":"Involvement of toll-like receptor 9 polymorphism in cervical cancer development","volume":"39","author":"A Roszak","year":"2012","journal-title":"Mol Biol Rep"},{"key":"pone.0328449.ref047","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.humimm.2017.10.001","article-title":"Frequencies of gene variant CCR5-Delta32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers","volume":"78","author":"UV Solloch","year":"2017","journal-title":"Hum Immunol"},{"issue":"6593","key":"pone.0328449.ref048","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"M Samson","year":"1996","journal-title":"Nature"},{"issue":"4","key":"pone.0328449.ref049","first-page":"244","article-title":"Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion","volume":"38","author":"EL Barr","year":"2005","journal-title":"J Microbiol Immunol Infect"},{"issue":"11","key":"pone.0328449.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030339","article-title":"The Geographic Spread of the CCR5 \u039432 HIV-Resistance Allele","volume":"3","author":"J Novembre","year":"2005","journal-title":"PLoS Biol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:23:52Z","timestamp":1754414632000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328449"}},"subtitle":[],"editor":[{"given":"Guangming","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328449","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]}}}